✦ LIBER ✦

Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide

✍ Scribed by Christine Theodore; Mohamed Azab; Jean-Pierre Droz; Alain Assouline; Martine George; Gilles Piot; Dominique Bellet; Guy Michel; Jean-Louis Amiel

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 404 KB
Volume: 64
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19891101)64:9<1824::aid-cncr2820640911>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, vinblastine, and bleomycin co

Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk. Gestational trophoblastic tumors

✍ Mohamed Azab; Jean-Pierre Droz; Christine Theodore; Jean-Pierre Wolff; Jean-Loui 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

Germ cell malignancies of the ovary. Tre

Germ cell malignancies of the ovary. Treatment with vinblastine, actinomycin D, bleomycin and cisplatin containing chemotherapy combinations

✍ James E. Bradof; Dr. Thomas B. Hakes; Manuel Ochoa; Robert Golbey 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB 👁 2 views

Seventeen patients with malignant ovarian germ cell tumors were treated with vinblastine, actinomycin D, bleomycin and cisplatin containing combinations. Many of these patients were heavily pretreated. Thirteen patients had objectively measurable disease and ten (77%) had an objective response (CR o

High dose chemotherapy with ifosfamide,

High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults

✍ Jean-Pierre Droz; Pierre Biron; Jean-Pierre Lotz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

Treatment of advanced non-small cell lun

Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C

✍ Paul J. Hesketh; Sualp Tansan; Priscilla B. Caguioa; Ann Hesketh; Rita Blanchard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

High incidence of treatment failure with

High incidence of treatment failure with vincristine, etoposide, epirubicin, and prednisolone chemotherapy with successful salvage in childhood Hodgkin disease

✍ Ekert, Henry; Toogood, Ian; Downie, Peter; Smith, Peter J.; Macfarlane, S.; Whit 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Background and Procedure. In an attempt to further reduce the long-term toxicity of chemotherapy for childhood Hodgkin disease (HD), the Australian and New Zealand Children's Cancer Study Group between 1990 and 1996 enrolled 53 children with biopsy-proven and imaging-staged HD into a chemotherapyonl

A combination chemotherapy with low dose

A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study

✍ Shin-ichiro Kuriya; Kazunori Murai; Yasuro Miyairi; Taiju Utsugisawa; Yasushi Na 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 1 views

## BACKGROUND. Even now, no definitely effective therapy is inducted to high risk myelodysplastic syndromes (MDS) and their leukemic stage (MDS-AML) except bone marrow transplantation. ## METHODS. Ten patients with high risk MDS and 6 with MDS-AML were treated with daily low doses of cytarabine